A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer.

Trial Profile

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2017

At a glance

  • Drugs Sipuleucel-T (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Acronyms PROCEED
  • Sponsors Dendreon Corporation
  • Most Recent Events

    • 13 May 2017 According to a Dendron media release, results from this study were presented at the 112th American Urological Association (AUA) Annual Meeting.
    • 13 May 2017 Results published in a Dendron media release.
    • 21 Apr 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top